End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.035 CAD | -12.50% | -12.50% | +40.00% |
Feb. 28 | NAVCO Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023 | CI |
Sales 2022 | 58.73K 42.93K | Sales 2023 | - | Capitalization | 1.21M 885K |
---|---|---|---|---|---|
Net income 2022 | - 0 | Net income 2023 | -2M -1.46M | EV / Sales 2022 * | - |
Net Debt 2022 | 896K 655K | Net Debt 2023 | 370K 270K | EV / Sales 2023 | - |
P/E ratio 2022 * |
-
| P/E ratio 2023 |
-0.42
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99% |
1 day | -12.50% |
1st Jan change | Capi. | |
---|---|---|
+10.21% | 381B | |
+1.76% | 120B | |
+11.13% | 72.81B | |
-15.18% | 63.83B | |
+1.83% | 53.41B | |
-10.15% | 37.09B | |
+2.17% | 32.95B | |
+5.00% | 17.08B | |
+7.21% | 14.47B |
- Stock Market
- Equities
- NAV Stock
- NAV Stock